Equities

Erasca Inc

ERAS:NSQ

Erasca Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.14
  • Today's Change0.03 / 0.96%
  • Shares traded1.51m
  • 1 Year change+42.73%
  • Beta1.2413
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Erasca Inc fell by 191.14m. Cash Flow from Financing totalled 1.30m or -- of revenues. In addition the company used 101.22m for operations while cash used for investing totalled 91.22m.
Cash flow per share-0.9208
Price/Cash flow per share--
Book value per share1.65
Tangible book value per share1.65
More ▼

Balance sheet in USDView more

Erasca Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio16.79
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.